James Aloysius Brady - Mar 28, 2025 Form 3 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role
Director
Signature
/s/ Beth Hecht, Attorney-in-Fact
Stock symbol
XERS
Transactions as of
Mar 28, 2025
Transactions value $
$0
Form type
3
Date filed
3/28/2025, 04:44 PM
Previous filing
Apr 30, 2024
Next filing
Apr 29, 2025

No securities are beneficially owned.